Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 17, 2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2026
ISDE guidelines on the management of cT2N0 esophageal cancer.
Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: January 23, 2026
KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma.
Journal: JAMA network open
Published: January 08, 2025
Reply to 'NALIRIFOX in the frontline for metastatic pancreatic cancer: evidence beyond NAPOLI 3'.
Journal: Nature reviews. Clinical oncology
Published: October 25, 2024
NALIRIFOX for metastatic pancreatic adenocarcinoma: hope or hype?
Journal: Nature reviews. Clinical oncology
Published: April 25, 2024
Durable response to first-line PARP inhibition in BRCA-mutated metastatic cholangiocarcinoma: case report.
Journal: Journal of gastrointestinal oncology
Published: July 18, 2023
A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 17, 2022
Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel + Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma.
Journal: Pancreas
Published: August 04, 2021
Last Updated: 09/26/2026